Research On The Legal System Of Drug Market Supervision In China

China's medical system after more than 30 years of time changes,changes,which on the drug regulatory system,there are still many problems,not only in the medication when patients difficult to dispel doubts,to drug regulators also bring heavy test.Drug safety is a top priority for national health and social stability,a country's macro management level,institutional innovation capacity and national standard of living.This paper starts with the case of "Qi Er Yao" and "poison vaccine",and leads to the thinking of China's drug access system,and analyzes in detail the defects and shortcomings of China's drug regulatory system.Through a brief introduction to the United States and Japan,the drug regulatory model,the lack of its long,combined with the author's experience,from the perspective of economic law,detailed analysis,enumerate the improvement of China's drug regulatory system measures and measures,The market order to promote the progress of China's drug regulatory system of legal process.